RxDoctor Payments DataLook up a doctor →

Christina Feser, DO

Dermatology · Clarksville, TNNPI 1902122096

Payments from drug & device makers

$3,704,171in general payments, 2019–2025

Across 2,406 payments — averaging $1539.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$1.6M
  • Eli Lilly$408K
  • Amgen$363K
  • Takeda Pharmaceuticals U.S.A., Inc.$281K
  • Lilly USA, LLC$254K
  • AbbVie$254K
  • plus $533K from 40 others
$70,119in research payments, 2019–2025

Across 3 payments — averaging $23,373 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$70K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,704,171 in reported general payments places this provider in the 95th percentile of 209 dermatology providers in Tennessee.

See all dermatology providers in Tennessee

Medicare billing

Part B allowed, 2024
$401,975
Medicare patients
1,108
Services billed
7,639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →